O2TODAY Announces Agreement to Develop Antimicrobial Face Masks with SINTX Technologies, Inc. to Help Prevent Spread of COVID-19 and Other Viral Diseases
View the full release here: https://www.businesswire.com/news/home/20200804005378/en/
- View the full release here: https://www.businesswire.com/news/home/20200804005378/en/
One of the mask styles O2TODAY and SINTX plan to develop research upon. - O2TODAY and SINTX plan to jointly fund collaborative research and product development activities in Salt Lake City, Utah, with the input of external laboratories as well.
- Upon the joint development of an antimicrobial mask, the companies will enter a commercialization agreement under which O2TODAY will be the exclusive global distributor for face masks & replacement filters containing SINTXs silicon nitride.
- The collaboration with SINTX is intended to develop and bring to market a much-needed product in the fight against COVID-19.